ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 68 filers reported holding ONCOMED PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $13,000 | -64.9% | 5,500 | -52.9% | 0.00% | – |
| Q1 2018 | $37,000 | -86.6% | 11,678 | -86.0% | 0.00% | – |
| Q2 2017 | $277,000 | +454.0% | 83,345 | +1426.7% | 0.00% | – |
| Q1 2017 | $50,000 | +19.0% | 5,459 | 0.0% | 0.00% | – |
| Q4 2016 | $42,000 | -35.4% | 5,459 | -3.9% | 0.00% | – |
| Q3 2016 | $65,000 | -12.2% | 5,681 | -6.3% | 0.00% | – |
| Q2 2016 | $74,000 | -83.4% | 6,060 | -86.3% | 0.00% | – |
| Q1 2016 | $447,000 | -85.8% | 44,242 | -68.2% | 0.00% | -100.0% |
| Q4 2015 | $3,137,000 | +24.2% | 139,178 | +24.0% | 0.00% | 0.0% |
| Q2 2015 | $2,526,000 | +17.7% | 112,283 | +34.9% | 0.00% | – |
| Q1 2015 | $2,146,000 | +158.9% | 83,247 | +90.1% | 0.00% | – |
| Q3 2014 | $829,000 | +56.7% | 43,785 | +92.8% | 0.00% | – |
| Q2 2014 | $529,000 | -65.4% | 22,714 | -77.2% | 0.00% | – |
| Q3 2013 | $1,528,000 | – | 99,775 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 1,839,730 | $16,944,000 | 4.17% |
| BVF INC/IL | 1,760,489 | $16,214,000 | 2.76% |
| Iguana Healthcare Management, LLC | 490,000 | $4,513,000 | 2.23% |
| Broadfin Capital, LLC | 300,000 | $2,763,000 | 0.34% |
| TURNER INVESTMENTS LLC | 38,083 | $351,000 | 0.23% |
| Birchview Capital, LP | 34,689 | $319,000 | 0.18% |
| Piermont Capital Management Inc. | 52,195 | $481,000 | 0.12% |
| Cannell & Co. | 331,296 | $3,051,000 | 0.11% |
| NJ State Employees Deferred Compensation Plan | 48,000 | $442,000 | 0.08% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 324,350 | $2,987,000 | 0.07% |